This podcast episode delves into several significant topics, including the lawsuit between Elon Musk and OpenAI, the challenges faced by Google in the field of AI, and Apple's decision to end its car project. It also explores the trend of tech companies initiating dividends and share buybacks, patent cliffs in the pharmaceutical industry, and the potential impact of biosimilars on the market. The episode also discusses strategies used by pharmaceutical companies to extend patent life and the pros and cons of dynamic pricing in businesses, particularly in the restaurant industry.
Sign in to continue reading, translating and more.
Continue
